ORCHARD THERAPEUTICS PLC Depreciation and Amortization
ORCHARD THERAPEUTICS PLC reported Depreciation and Amortization of $1.95 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2023-11-13
- ORCHARD THERAPEUTICS PLC depreciation, depletion and amortization for the quarter ending 2023-09-30 was $652.00K, a 0.31% decline year-over-year.
- ORCHARD THERAPEUTICS PLC depreciation, depletion and amortization for the quarter ending 2023-06-30 was $655.00K, a 0.30% decline year-over-year.
- ORCHARD THERAPEUTICS PLC depreciation, depletion and amortization for the quarter ending 2023-03-31 was $643.00K, a 9.31% decline year-over-year.
- ORCHARD THERAPEUTICS PLC depreciation, depletion and amortization for the quarter ending 2022-12-31 was $721.00K, a 6.66% increase year-over-year.
- ORCHARD THERAPEUTICS PLC depreciation, depletion and amortization for fiscal 2022 was $2.74M, a 17.79% increase from fiscal 2021.
- ORCHARD THERAPEUTICS PLC depreciation, depletion and amortization for fiscal 2021 was $2.33M, a 16.12% increase from fiscal 2020.
- ORCHARD THERAPEUTICS PLC depreciation, depletion and amortization for fiscal 2020 was $2.00M.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month |
|---|---|---|---|---|
| 2023-09-30 | $652.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.31M derived: sum of 2 quarters · filed 2023-11-13 | $1.95M 10-Q · filed 2023-11-13 | $2.67M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | $655.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.30M 10-Q · filed 2023-08-10 | $2.02M derived: sum of 3 quarters · filed 2023-08-10 | $2.67M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-03-31 | $643.00K 10-Q · filed 2023-05-15 | $1.36M derived: sum of 2 quarters · filed 2023-05-15 | $2.02M derived: sum of 3 quarters · filed 2023-11-13 | $2.67M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-12-31 | $721.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $1.38M derived: sum of 2 quarters · filed 2023-11-13 | $2.03M derived: sum of 3 quarters · filed 2023-11-13 | $2.74M 10-K · filed 2023-03-14 |
| 2022-09-30 | $654.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.31M derived: sum of 2 quarters · filed 2023-11-13 | $2.02M 10-Q · filed 2023-11-13 | $2.70M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $657.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.37M 10-Q · filed 2023-08-10 | $2.04M derived: sum of 3 quarters · filed 2023-08-10 | $2.69M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $709.00K 10-Q · filed 2023-05-15 | $1.39M derived: sum of 2 quarters · filed 2023-05-15 | $2.03M derived: sum of 3 quarters · filed 2023-05-15 | $2.54M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $676.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $1.32M derived: sum of 2 quarters · filed 2023-03-14 | $1.83M derived: sum of 3 quarters · filed 2023-03-14 | $2.33M 10-K · filed 2023-03-14 |
| 2021-09-30 | $648.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.16M derived: sum of 2 quarters · filed 2022-11-14 | $1.65M 10-Q · filed 2022-11-14 | $2.10M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $508.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.00M 10-Q · filed 2022-08-04 | $1.45M derived: sum of 3 quarters · filed 2022-08-04 | |
| 2021-03-31 | $495.00K 10-Q · filed 2022-05-12 | $941.00K derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $446.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $2.00M 10-K · filed 2022-03-30 | ||
| 2020-09-30 | $1.56M 10-Q · filed 2021-11-04 |